Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
san francisco blog main
san francisco top stories
sanofi
3
×
biotech
cancer
cancer drugs
clinical trials
deals
ipo
national top stories
revolution medicines
san francisco
the column group
third rock ventures
warp drive bio
amgen
biontech
boehringer ingelheim
boston
cobimetinib
colorectal cancer
curevac
eli lilly
infectious diseases
investing
john shiver
mark goldsmith
moderna therapeutics
mrna
new york blog main
new york top stories
non-small cell lung cancer
pancreatic cancer
ras
roche
translate bio
What
cancer
3
×
medicines
3
×
ipo
pharmaceutical
proteins
research
revolution
bets
bio
cancer’s
comes
companies
cut
date
deal
despite
disease
drug
effective
enticed
evidence
family
frontiers
hardest
hasn’t
hit
hottest
hunters
known
latest
maps
messenger
molecules
mrna
multiple
new
parlance
play
primarily
promise
Language
unset
Current search:
medicines
×
cancer
×
sanofi
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines